Corrigendum to “7-Deacetyl-gedunin suppresses proliferation of Human rheumatoid arthritis synovial fibroblast through activation of Nrf2/ARE signalling” [Int. Immunopharmacol. 107 (2022) 108557] (International Immunopharmacology (2022) 112, (S1567576922006646), (10.1016/j.intimp.2022.109180))

doi:10.1016/j.intimp.2023.110640

Residential College	false
Status	已發表Published
	Corrigendum to “7-Deacetyl-gedunin suppresses proliferation of Human rheumatoid arthritis synovial fibroblast through activation of Nrf2/ARE signalling” [Int. Immunopharmacol. 107 (2022) 108557] (International Immunopharmacology (2022) 112, (S1567576922006646), (10.1016/j.intimp.2022.109180))
	Chen, Jian Yu 1; Zhu, Guo Yuan 3; Sun, Yi Bin 1; Wu, Yue Chan 4; Wu, Bao Kun 5; Zheng, Wan Ting 1; Ma, Xue Qin 2; Zheng, Yan Fang 1
	2023-09-01
DOI	10.1016/j.intimp.2023.110640
Language	其他語言Other
URL	View the original
Scopus ID	2-s2.0-85166306166
Fulltext Access	View Full-Text via DOI View Full-Text via Web of Science View Full-Text via Scopus
Citation statistics
Document Type	Other
Collection	University of Macau
Affiliation	1.Department of Pharmacology, School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, No.1, Huatuo Road, Min Hou Shang Jie, 350122, China 2.Department of Pharmaceutical Analysis, School of Pharmacy, Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, Yinchuan, 1160 Shenli Street, 750004, China 3.State Key Laboratory of Quality Research in Chinese Medicine/Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macao 4.LiuHe Township Health Center, Huang Gang, No. 63, LiuHe Road, Qi Chun Liu He, 436328, China 5.AIM Explorer Life Sciences Co. Ltd, Gemdale Viseem MinHang Technology & Industrial Park, ShangHai, No. 1288, Zhongchun Road, Minhang, 201108, China
Recommended Citation GB/T 7714	Chen, Jian Yu,Zhu, Guo Yuan,Sun, Yi Bin,et al. Corrigendum to “7-Deacetyl-gedunin suppresses proliferation of Human rheumatoid arthritis synovial fibroblast through activation of Nrf2/ARE signalling” [Int. Immunopharmacol. 107 (2022) 108557] (International Immunopharmacology (2022) 112, (S1567576922006646), (10.1016/j.intimp.2022.109180)). 2023-09-01.

Files in This Item:
There are no files associated with this item.

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Affiliation No.
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh